FindTrial
Sign In

A clinical trial to study red cell distribution width and neutrophil lymphocyte ratio as a prognostic marker for mortality in head injury patients.

RED BLOOD CELL DISTRIBUTION WIDTH AND NEUTROPHIL LYMPHOCYTE RATIO AS A PROGNOSTIC BIOMARKER FOR MORTALITY IN TRAUMATIC BRAIN INJURY

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2019/06/019566
Enrollment
100
Registered
2019-06-07
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: V879- Person injured in other specified(collision)(noncollision) transport accidents involving nonmotor vehicle (traffic)

Interventions

Control Intervention1: Nill: After obtaining written consent from patients, 100 patients will be included.For each patient with history of traumatic brain injury, a complete diagnostic work-up will be

Sponsors

none
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Traumatic brain injury diagnosis will be based on the history and CT head finding of patient, patients with age of over 16-60 years will be included

Exclusion criteria

Exclusion criteria: Patients with severe multiple injury, visceral hemorrhage, anemia, cardiovascular disease, diabetes or with incomplete medical record will be excluded.

Design outcomes

Primary

MeasureTime frame
28 days maortality since admissionTimepoint: In 28 days ofadmission; mortality will be recorded—

Secondary

MeasureTime frame
total number of ventillator days as well as days spent in icu will be recordedTimepoint: 6 month—

Countries

India

Contacts

Public ContactDr Ghanshyam Yadav

Banaras Hindu University Varanasi

ghanshyambhu1976@gmail.com9838894169

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026